dc.contributor.author | Ekmekci, Ahmet | |
dc.contributor.author | Tufan, Fatih | |
dc.contributor.author | Demirturk, Mustafa | |
dc.contributor.author | Cagatay, Arif Atahan | |
dc.contributor.author | Yakar, Fatih | |
dc.date.accessioned | 2021-03-05T09:52:49Z | |
dc.date.available | 2021-03-05T09:52:49Z | |
dc.date.issued | 2008 | |
dc.identifier.citation | Ekmekci A., Yakar F., Tufan F., Demirturk M., Cagatay A. A. , "A case report of bone marrow suppression caused by piperacillin tazobactam", NOBEL MEDICUS, cilt.4, ss.28-30, 2008 | |
dc.identifier.issn | 1305-2381 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_a01543a4-823a-4bd7-a828-d59b7007d1fe | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/107391 | |
dc.description.abstract | Piperacillin/tazobactam (PT) is a commonly prescribed antibiotic and is generally considered safe. During treatment with piperacillin/tazobactam bone marrow suppression can rarely be seen as a serious adverse effect. We report here a case of PT induced bone marrow suppression. A 58 year old man was being treated with PT for empyema. After 20 days of treatment, he developed neutropenia and thrombocytopenia. | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Temel Tıp Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | TIP, GENEL & İÇECEK | |
dc.title | A case report of bone marrow suppression caused by piperacillin tazobactam | |
dc.type | Makale | |
dc.relation.journal | NOBEL MEDICUS | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 4 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 28 | |
dc.identifier.endpage | 30 | |
dc.contributor.firstauthorID | 67681 | |